AI assistant
JHS Svendgaard Laboratories Ltd. Interim / Quarterly Report 2021
61621_rns_2021-02-08_ebc6259a-7966-4e1e-94bf-cab4e5aafaf0.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Date: February 08, 2021
To,
The National Stock Exchange of India Limited "Exchange Plaza", Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai-400051
NSE Symbol: JHS
Subject: Clarification for financial results- Segment details not submitted
Ref: Email dated February 07, 2021
Dear Sir,
With reference to the captioned subject and SEBI Circular No CIR/CFD/FAC/62/2016 (Revised Formats for Financial Results and Implementation of IND-AS by Listed Entities) dated July 05, 2016 read with Circular No. CIR/CFD/CMD/15/2015 (Format for Publishing Financial Results) dated 30" November, 2015, following these circulars; we are hereby submitting our segment reporting disclosure as per IND-AS 108.
This for your kind information and record.
For JHS Svendgaard Laboratories Limited
' IHS Svendgaard Laboratories Limited
or Ye . Company Secretary & Kirti Maheshwari Compliance Officer Company Secretary and Compliance Officer
T q | ' | Registered Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil-Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA ie al | | | \ | Tel. : +91-1702-302119/121/102 - Fax : +91-1702-302125
| Annexure IV | ||||
|---|---|---|---|---|
| Reporting of Segment wise Revenue, Results, Assets and Liabilities along with the quarterly results | (Rs in Lakhs) | |||
| Particulars | Quarter EndedJune 30, 2020 | Quarter Ended Quarter EndedMarch 31, 2020 June 30,2019 March 31, 2020 | Year ended | |
| Unaudited | Audited | Unaudited | Audited | |
| 1. Segment Revenue(net sale/income from each segment should be | ||||
| disclosed under this head) | ||||
| (a) Manufacturing Business(b) Other than Manufacturing Business | 1,611.4546.59 | 4,049.97128.05 | 2,325.72310.00 | 13,295.61898.60 |
| (c) Retail Businesss | 25.91 | 89.50 | 56.64 | 263.69 |
| Total | 1,683.95 | 4,267.52 | 2,692.36 | 14,457.90 |
| Less : Inter Segment RevenueNet Sales/Income From Operations | 6.601,677.34 | 142.024,125.49 | 156.882,535.48 | 546.4813,911.42 |
| 2. Segment Results Profit(+)/Loss (-) before tax and | ||||
| interest from each segment | ||||
| (a) Manufacturing Business | (202.06) | (191.96) | 103.92 | 315.20 |
| (b) Other than Manufacturing Business(c) Retail Businesss | (35.90)(48.42) | (165.53)0.64 | (168.16)9.67 | (709.87)5.61 |
| (286.38) | (356.85) | (54.57) | (389.06) | |
| 3. Segment Assets | ||||
| (a) Manufacturing Business | 21,744.99 | 22,908.71 | 22,220.81 | 22,908.71 |
| (b) Other than Manufacturing Business | 2,715.36 | 2,742.61 | 3,199.76 | 2,742.61 |
| (c) Retail BusinesssLess: Inter Segment Assets | 1,089.66(2,636.21) | 1,197.81(2,757.53) | 823.28(2,826.02) | 1,197.81(2,757.53) |
| 22,913.79 | 24,091.60 | 23,417.83 | 24,091.60 | |
| TotalTotal4. Segment Liabilities | ||||
| (a) Manufacturing Business | 3,801.46 | 4,758.91 | 4,198.14 | 4,758.91 |
| (b) Other than Manufacturing Business(c) Retail Businesss | 1,598.24533.29 | 1,630.63603.51 | 1,867.80211.75 | 1,630.63603,51 |
| Less: Inter Segment Liabilities | (1,340.72) | (1,361.10) | (1,583.93) | (1,361.10) |
iS Svendgaard Laboratories Limited be Company Secretary & Compliance Officer